224,600 Shares in Aveanna Healthcare Holdings Inc. $AVAH Bought by Cantor Fitzgerald Investment Advisors L.P.

Key Points

• Cantor Fitzgerald Investment Advisors initiated a position in Aveanna Healthcare by purchasing 224,600 shares valued at approximately $2.79 million, representing about 0.10% of the company.
• Aveanna reported quarterly earnings of $0.22 per share, beating estimates by $0.05, while revenue of $670.48 million also exceeded expectations. Institutional investors collectively own 87.96% of the stock.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $14.06, although company insiders sold shares recently, including the CEO’s sale of 90,000 shares.

Cantor Fitzgerald Investment Advisors L.P. bought a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm bought 224,600 shares of the company's stock, valued at approximately $2,787,000. Cantor Fitzgerald Investment Advisors L.P. owned approximately 0.10% of Aveanna Healthcare as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Nisa Investment Advisors LLC increased its stake in Aveanna Healthcare by 104.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 11,181 shares of the company's stock valued at $139,000 after purchasing an additional 5,720 shares in the last quarter. Revisor Wealth Management LLC acquired a new position in Aveanna Healthcare during the third quarter worth $181,000. GK Wealth Management LLC acquired a new position in Aveanna Healthcare during the third quarter worth $90,000. Farther Finance Advisors LLC lifted its stake in shares of Aveanna Healthcare by 217.1% in the third quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company's stock valued at $37,000 after buying an additional 2,039 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new position in shares of Aveanna Healthcare in the second quarter valued at $197,000. Institutional investors and hedge funds own 87.96% of the company's stock.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $12.99 on Thursday. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $14.71. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $2.83 billion, a price-to-earnings ratio of 10.56, a PEG ratio of 0.78 and a beta of 1.95. The company has a fifty day moving average price of $13.04 and a 200-day moving average price of $9.71.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The company had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. As a group, equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.77 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jeff Shaner sold 90,000 shares of the company's stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $1,035,000.00. Following the completion of the transaction, the chief executive officer directly owned 2,561,972 shares of the company's stock, valued at $29,462,678. This represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Edwin C. Reisz sold 50,000 shares of the stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $575,000.00. Following the sale, the insider directly owned 1,397,897 shares of the company's stock, valued at $16,075,815.50. The trade was a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 48,566,081 shares of company stock worth $558,509,932 in the last ninety days. 5.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on AVAH shares. BMO Capital Markets lifted their price objective on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an "outperform" rating in a report on Friday, August 14th. UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a "neutral" rating in a report on Friday, August 14th. Truist Financial upped their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a "hold" rating in a report on Monday, August 24th. Barclays raised their price target on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an "overweight" rating in a research report on Friday, August 28th. Finally, Wall Street Zen downgraded Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $14.06.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc NASDAQ: AVAH is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna's services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.